Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29076 | 193 | 48.4 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
1072 | 2 | TGF BETA//SMAD//ENDOGLIN | 9938 |
29076 | 1 | MIIP//BETAGLYCAN//T BETA RIII | 193 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MIIP | authKW | 659226 | 3% | 83% | 5 |
2 | BETAGLYCAN | authKW | 371344 | 7% | 18% | 13 |
3 | T BETA RIII | authKW | 316429 | 1% | 100% | 2 |
4 | THIOREDOXIN TAG FUSION PROTEIN | authKW | 316429 | 1% | 100% | 2 |
5 | LEHRSTUHL PHYSIOL CHEM 2 | address | 276865 | 4% | 25% | 7 |
6 | TGFBR3 | authKW | 263685 | 3% | 33% | 5 |
7 | TGF BETA RECEPTOR III | authKW | 210952 | 1% | 67% | 2 |
8 | BAS PL SCI | address | 158215 | 1% | 100% | 1 |
9 | BIOWISSEN AFTEN BIOZENTRUM | address | 158215 | 1% | 100% | 1 |
10 | BMP RECEPTOR KINASES AND INHIBITORS | authKW | 158215 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 985 | 59% | 0% | 113 |
2 | Cell Biology | 519 | 27% | 0% | 53 |
3 | Oncology | 197 | 18% | 0% | 35 |
4 | Biophysics | 197 | 12% | 0% | 24 |
5 | Biochemical Research Methods | 59 | 7% | 0% | 13 |
6 | Biotechnology & Applied Microbiology | 19 | 6% | 0% | 11 |
7 | Genetics & Heredity | 11 | 5% | 0% | 9 |
8 | Endocrinology & Metabolism | 11 | 4% | 0% | 8 |
9 | Spectroscopy | 2 | 2% | 0% | 3 |
10 | Physiology | 2 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEHRSTUHL PHYSIOL CHEM 2 | 276865 | 4% | 25% | 7 |
2 | BAS PL SCI | 158215 | 1% | 100% | 1 |
3 | BIOWISSEN AFTEN BIOZENTRUM | 158215 | 1% | 100% | 1 |
4 | CELL SIGNALING PROTEOM GRP | 158215 | 1% | 100% | 1 |
5 | CELL SUR E RECOGNOT GRP | 158215 | 1% | 100% | 1 |
6 | CLIN PHARMACOLCHINESE EDUC MINIST | 158215 | 1% | 100% | 1 |
7 | CLIN PHARMAFFILIATED HOSP 2 | 158215 | 1% | 100% | 1 |
8 | DEUT FOR UNGSGEMEIN AFT FOR UNGZENTRUM | 158215 | 1% | 100% | 1 |
9 | DUKE IGSP | 158215 | 1% | 100% | 1 |
10 | JULIUS VON SACHS BIOWISSEN BIOZENTRUM | 158215 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROFESSIONAL ENGINEERING | 5556 | 2% | 1% | 3 |
2 | NATURE STRUCTURAL BIOLOGY | 1600 | 2% | 0% | 4 |
3 | PROTEIN EXPRESSION AND PURIFICATION | 1223 | 3% | 0% | 6 |
4 | CYTOKINE & GROWTH FACTOR REVIEWS | 787 | 1% | 0% | 2 |
5 | ONCOLOGY REPORTS | 773 | 4% | 0% | 7 |
6 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | 668 | 1% | 0% | 1 |
7 | VITAMINS AND HORMONES | 649 | 1% | 0% | 1 |
8 | CELLULAR SIGNALLING | 575 | 2% | 0% | 4 |
9 | JOURNAL OF BIOMOLECULAR NMR | 530 | 2% | 0% | 3 |
10 | KEIO UNIVERSITY SYMPOSIA FOR LIFE SCIENCE AND MEDICINE | 517 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIIP | 659226 | 3% | 83% | 5 | Search MIIP | Search MIIP |
2 | BETAGLYCAN | 371344 | 7% | 18% | 13 | Search BETAGLYCAN | Search BETAGLYCAN |
3 | T BETA RIII | 316429 | 1% | 100% | 2 | Search T+BETA+RIII | Search T+BETA+RIII |
4 | THIOREDOXIN TAG FUSION PROTEIN | 316429 | 1% | 100% | 2 | Search THIOREDOXIN+TAG+FUSION+PROTEIN | Search THIOREDOXIN+TAG+FUSION+PROTEIN |
5 | TGFBR3 | 263685 | 3% | 33% | 5 | Search TGFBR3 | Search TGFBR3 |
6 | TGF BETA RECEPTOR III | 210952 | 1% | 67% | 2 | Search TGF+BETA+RECEPTOR+III | Search TGF+BETA+RECEPTOR+III |
7 | BMP RECEPTOR KINASES AND INHIBITORS | 158215 | 1% | 100% | 1 | Search BMP+RECEPTOR+KINASES+AND+INHIBITORS | Search BMP+RECEPTOR+KINASES+AND+INHIBITORS |
8 | CYSTINE NETWORK | 158215 | 1% | 100% | 1 | Search CYSTINE+NETWORK | Search CYSTINE+NETWORK |
9 | DIAGNOSTIC TOOLS FOR LUNG CANCER | 158215 | 1% | 100% | 1 | Search DIAGNOSTIC+TOOLS+FOR+LUNG+CANCER | Search DIAGNOSTIC+TOOLS+FOR+LUNG+CANCER |
10 | EPIGENETICS OF LUNG CANCER | 158215 | 1% | 100% | 1 | Search EPIGENETICS+OF+LUNG+CANCER | Search EPIGENETICS+OF+LUNG+CANCER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZAKRZEWSKI, PK , NOWACKA-ZAWISZA, M , SEMCZUK, A , RECHBERGER, T , GALCZYNSKI, K , KRAJEWSKA, WM , (2016) SIGNIFICANCE OF TGFBR3 ALLELIC LOSS IN THE DEREGULATION OF TGF BETA SIGNALING IN PRIMARY HUMAN ENDOMETRIAL CARCINOMAS.ONCOLOGY REPORTS. VOL. 35. ISSUE 2. P. 932 -938 | 25 | 57% | 0 |
2 | GATZA, CE , OH, SY , BLOBE, GC , (2010) ROLES FOR THE TYPE III TGF-BETA RECEPTOR IN HUMAN CANCER.CELLULAR SIGNALLING. VOL. 22. ISSUE 8. P. 1163-1174 | 36 | 30% | 72 |
3 | TAZAT, K , HECTOR-GREENE, M , BLOBE, GC , HENIS, YI , (2015) T BETA RIII INDEPENDENTLY BINDS TYPE I AND TYPE II TGF-BETA RECEPTORS TO INHIBIT TGF-BETA SIGNALING.MOLECULAR BIOLOGY OF THE CELL. VOL. 26. ISSUE 19. P. 3535 -3545 | 23 | 41% | 3 |
4 | HINCK, AP , O'CONNOR-MCCOURT, MD , (2011) STRUCTURES OF TGF-BETA RECEPTOR COMPLEXES: IMPLICATIONS FOR FUNCTION AND THERAPEUTIC INTERVENTION USING LIGAND TRAPS.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 12. ISSUE 12. P. 2081-2098 | 34 | 29% | 6 |
5 | BILANDZIC, M , STENVERS, KL , (2011) BETAGLYCAN: A MULTIFUNCTIONAL ACCESSORY.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 339. ISSUE 1-2. P. 180 -189 | 31 | 29% | 27 |
6 | BLAIR, CR , STONE, JB , WELLS, RG , (2011) THE TYPE III TGF-BETA RECEPTOR BETAGLYCAN TRANSMEMBRANE-CYTOPLASMIC DOMAIN FRAGMENT IS STABLE AFTER ECTODOMAIN CLEAVAGE AND IS A SUBSTRATE OF THE INTRAMEMBRANE PROTEASE GAMMA-SECRETASE.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1813. ISSUE 2. P. 332-339 | 26 | 35% | 9 |
7 | LEE, JD , HEMPEL, N , LEE, NY , BLOBE, GC , (2010) THE TYPE III TGF-BETA RECEPTOR SUPPRESSES BREAST CANCER PROGRESSION THROUGH GIPC-MEDIATED INHIBITION OF TGF-BETA SIGNALING.CARCINOGENESIS. VOL. 31. ISSUE 2. P. 175 -183 | 15 | 54% | 23 |
8 | EHRLICH, M , GUTMAN, O , KNAUS, P , HENIS, YI , (2012) OLIGOMERIC INTERACTIONS OF TGF-BETA AND BMP RECEPTORS.FEBS LETTERS. VOL. 586. ISSUE 14. P. 1885 -1896 | 31 | 23% | 22 |
9 | GROPPE, J , HINCK, CS , SAMAVARCHI-TEHRANI, P , ZUBIETA, C , SCHUERMANN, JP , TAYLOR, AB , SCHWARZ, PM , WRANA, JL , HINCK, AP , (2008) COOPERATIVE ASSEMBLY OF TGF-BETA SUPERFAMILY SIGNALING COMPLEXES IS MEDIATED BY TWO DISPARATE MECHANISMS AND DISTINCT MODES OF RECEPTOR BINDING.MOLECULAR CELL. VOL. 29. ISSUE 2. P. 157-168 | 19 | 35% | 102 |
10 | ZAKRZEWSKI, PK , MOKROSINSKI, J , CYGANKIEWICZ, AI , SEMCZUK, A , RECHBERGER, T , SKOMRA, D , KRAJEWSKA, WM , (2011) DYSREGULATION OF BETAGLYCAN EXPRESSION IN PRIMARY HUMAN ENDOMETRIAL CARCINOMAS.CANCER INVESTIGATION. VOL. 29. ISSUE 2. P. 137 -144 | 21 | 36% | 1 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 1881 | TGF BETA RECEPTORS//TRANSFORMING GROWTH FACTOR BETA//TGF BETA |
2 | 20430 | PROXIMAL SYMPHALANGISM//SYMPHALANGISM//NOG |
3 | 12726 | BONE MORPHOGENETIC PROTEIN 9//BMP9//BONE MORPHOGENETIC PROTEIN |
4 | 1117 | SMAD//SMAD4//TGF BETA |
5 | 14371 | ENDOGLIN//CD105//TRC105 |
6 | 22222 | CRIPTO 1//CRIPTO//TUMOR GROWTH TOR SECT |
7 | 843 | ACTIVIN//INHIBIN//FOLLISTATIN |
8 | 22102 | GREMLIN//GREMLIN 1//CRIM1 |
9 | 37247 | CD109//SYF2//ANTIGEN CD109 |
10 | 13162 | TWISTED GASTRULATION//BRINKER//DPP |